US defense tech company Anduril Industries is in discussions with investors over a new funding round that could value the company at approximately $100 billion. Reuters reported this on July 24, 2026, citing two people familiar with the matter. This comes just 72 days after Anduril announced its Series H, in which it raised $5 billion at a $61 billion valuation.
According to the report, one option under discussion is a structure in which investors would commit in advance to participating in a second round expected within roughly a year, with the next valuation rising based on Anduril's financial performance. However, neither the amount to be raised nor the terms have been finalized. The $100 billion figure highlights a substantial gap between the company's current revenue and expectations tied to the weapons factories and autonomous systems it has been building with capital invested ahead of demand.
From $61 Billion to a Two-Stage Proposal in 72 Days
According to Reuters, the new round and its valuation remain fluid, and it is not yet confirmed how much Anduril intends to raise. A company spokesperson said no decisions have been made regarding future fundraising, noting that as a private company, Anduril regularly evaluates fundraising options needed to support its business growth.
The most recent confirmed benchmark is the Series H round from May 13. Anduril raised $5 billion in a round led by Thrive Capital and Andreessen Horowitz, reaching a valuation of $61 billion. The reported $100 billion figure would represent an increase of $39 billion, or roughly 64%, from that point—though since it's unclear whether both figures are being compared on a pre-money or post-money basis under the same terms, this remains a simple comparison between a disclosed figure and a reported one. The gap between the two spans 10 weeks and 2 days.
What makes this proposed structure notable is its added complexity compared to a standard single-tranche round. In addition to this investment, investors would also be asked to commit to participating in a subsequent round expected within about a year. In that second round, a higher valuation could apply if Anduril meets certain financial targets.
Under this structure, Anduril would secure an early path to its next funding round. Investors, meanwhile, would be committing to additional investment at a future—and higher—valuation based on undisclosed performance conditions. Since it remains unknown which metrics would be used or how the investment obligation would change if targets aren't met, this cannot be properly evaluated until formal contract terms are released.
Roughly 45x Revenue of $2.2 Billion
In a May letter to investors, Anduril CEO Brian Schimpf revealed that 2025 revenue reached $2.2 billion, more than doubling from the previous year. He said headcount nearly doubled as well, and the number of systems transitioned from development to full-rate production more than doubled compared to prior totals. However, as a private company, Anduril does not disclose audited financial statements, including profit, cash flow, or backlog figures.
Dividing $100 billion by 2025 revenue of $2.2 billion yields a multiple of roughly 45.5x. Even at the Series H valuation of $61 billion, the multiple was about 27.7x. These are rough ratios of equity valuation to historical revenue, not equivalent to the EV/Sales metrics used for public companies. Even so, they indicate a level that only makes sense if investors are pricing in growth far outpacing the company's recent revenue trajectory.
Anduril itself has stated that it is aggressively deploying Series H proceeds into manufacturing capacity, R&D, and infrastructure. In other words, supporting this valuation will require not just growing revenue beyond $2.2 billion, but converting products and factories built through upfront investment into sustained government orders.
The $20 Billion Contract Is Neither Revenue Nor Backlog
Emblematic of the growth expectations surrounding Anduril is the 10-year enterprise-wide agreement the company signed with the US Army on March 13. With an estimated ceiling of $20 billion, the agreement consolidates what had previously been more than 120 separate procurement actions for Anduril products into a single framework. It consists of a 5-year base period plus 5 years of options.
However, the US Army has explicitly stated that the $20 billion figure represents "the maximum potential value, not an obligated amount." There is no guarantee that orders will reach the ceiling, and the figure does not directly translate into revenue or backlog. Competition will also remain in place for individual future programs. While the massive contract vehicle widens the door to potential demand, actual revenue will depend on whether Anduril wins individual orders.
There have also been more concrete developments. On June 17, the US Air Force awarded development and production contracts for Increment 1 of the Collaborative Combat Aircraft (CCA) program to General Atomics' YFQ-42 and Anduril's YFQ-44. Combined, the two aircraft are intended to field more than 150 combat-capable CCAs by the end of 2030. The specific quantities allocated to Anduril and the associated contract value have not been disclosed.
Competition also continues around the mission autonomy software that will operate the CCA fleet. The Air Force has selected six companies, including Anduril, for a contract vehicle and plans to select a primary provider by summer 2027. Winning the airframe production contract for the YFQ-44 does not guarantee exclusivity over the autonomous flight software. Verifying the $100 billion valuation will require looking beyond headline contract values to actual orders placed and market share secured after competition concludes.
Front-Loading Capital into Arsenal-1 and Thunder
Rather than waiting for formal government orders before building factories, Anduril has pursued a strategy of investing its own capital upfront to demonstrate production capacity. In August 2024, the company raised $1.5 billion in a Series F round at a $14 billion valuation, explicitly to fund manufacturing expansion. At the time, Anduril said the funds would go toward hiring, tooling, supply chains, and infrastructure.
Central to this effort is Arsenal-1, a production facility that, once complete, will span more than 5 million square feet, employ thousands of workers, and be designed to build tens of thousands of autonomous military systems annually. The facility links design, bills of materials, work instructions, and testing through software, making it easier to shift personnel and equipment across different products. The figure of tens of thousands of units per year represents a stated capacity target, not an achieved production record.
Investment is also expanding on the product side. On July 20, Anduril unveiled Thunder, an autonomous attack tiltrotor aircraft developed jointly with Archer Aviation. The company says it has conducted multiple test flights using a full-scale surrogate aircraft, but Thunder's own first flight isn't scheduled until 2027. No production contracts or deployment timeline have been announced.
The evidence needed to assess whether this funding round will actually materialize is more concrete than the headline $100 billion figure suggests. First, will a term sheet be signed, disclosing the total amount raised and the performance conditions attached to the proposed two-stage structure? Second, how much of the US Army's enterprise agreement will convert into actual orders, and how many of the more than 150 planned CCA aircraft will go to the YFQ-44? And third, will Arsenal-1 successfully ramp up to its planned production capacity and translate that into revenue growth in 2026? The answers to these questions will serve as the real test of the reported $100 billion price proposal. For now, the confirmed valuation stands at $61 billion.